Bank of Montreal
CDAK

Bank of Montreal’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History

Bank of Montreal’s Portfolio CDAK Stock Details CDAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-69,500
Closed -$288 – 4536
2022
Q2 		$288 Buy
+69,500
New +$244K ﹤0.01% 3035
2021
Q2 		– Sell
-232
Closed -$3K – 5272
2021
Q1 		$3K Sell
232
-645
-74% -$14K ﹤0.01% 4870
2020
Q4 		$23K Buy
+877
New +$11.6K ﹤0.01% 4367

Other funds holding CDAK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
APF
Alaska Permanent Fund Juneau, Alaska $1.44B AUM 23.16% 1-Year Est. Return
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $863M AUM 30.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Bank of Montreal's CDAK Position: Q3 2022 in Review

Bank of Montreal sold out of Codiak BioSciences, Inc. Common Stock (CDAK) in Q3 2022, closing a stake of 69,500 shares — an estimated $288 sold.

Bank of Montreal first reported a position in CDAK in Q4 2020 and held it in 3 quarters. The position peaked at $23K in Q4 2020. 48 funds tracked by Wall St. Rank hold CDAK as of Q3 2022.

  • Bank of Montreal reported no remaining Codiak BioSciences, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Bank of Montreal sold 69,500 Codiak BioSciences, Inc. Common Stock shares in Q3 2022, an estimated $288.
  • Bank of Montreal first reported a position in Codiak BioSciences, Inc. Common Stock in Q4 2020 and held it in 3 quarters.
  • Bank of Montreal's Codiak BioSciences, Inc. Common Stock position peaked at $23K in Q4 2020.
  • 48 funds tracked by Wall St. Rank held Codiak BioSciences, Inc. Common Stock as of Q3 2022.

Based on Bank of Montreal's 13F filing for Q3 2022, filed 10 Nov 2022.